Dr. James M. Klancnik

Dr. Klancnik utilizes all forms of ophthalmic imaging including fluorescein angiography, indocyanine green angiography, as well as noninvasive forms of imaging such as spectral domain optical coherence tomography, autofluorescence photography, and ultrasonography.

Dr. Klancnik is a magna cum laude graduate of Yale University. He earned his medical degree from Jefferson Medical College of Thomas Jefferson University and was elected to the Alpha Omega Alpha and Hobart Amory Hare honor medical societies. He completed his internship at the Lankenau Hospital and his ophthalmology residency at Wills Eye Hospital. He completed his medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University. He is an Assistant Professor of Clinical Ophthalmology at New York University School of Medicine.

Dr. Klancnik is a member of numerous medical organizations including the American Academy of Ophthalmology, American Society of Retinal Specialists, and Association for Research in Vision and Ophthalmology. He is an author of numerous peer-reviewed journal articles and book chapters and has presented at scientific meetings nationally and internationally. He is active in numerous clinical trials as principle or sub-investigator and serves as a reviewer for several ophthalmology journals.

Dr. Klancnik is rated as an Advanced provider by MediFind in the treatment of Usher Syndrome Type 2A. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion.

His clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years.